Virpax Pharmaceuticals Inc (NASDAQ:VRPX)’s traded shares stood at 0.46 million during the last session, with the company’s beta value hitting 1.18. At the close of trading, the stock’s price was $0.85, to imply an increase of 9.97% or $0.07 in intraday trading. The VRPX share’s 52-week high remains $9.50, putting it -1017.65% down since that peak but still an impressive 45.88% since price per share fell to its 52-week low of $0.46. The company has a valuation of $4.17M, with an average of 0.78 million shares in intraday trading volume over the past 10 days and average of 6.06 million shares over the past 3 months.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX) trade information
After registering a 9.97% upside in the last session, Virpax Pharmaceuticals Inc (VRPX) has traded red over the past five days. The 5-day price performance for the stock is -0.14%, and -43.54% over 30 days. With these gigs, the year-to-date price performance is -73.37%. Short interest in Virpax Pharmaceuticals Inc (NASDAQ:VRPX) saw shorts transact 0.27 million shares and set a 0.02 days time to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The extremes give us $3 and $3 for target low and target high price respectively. As such, VRPX has been trading -252.94% off suggested target high and -252.94% from its likely low.
Virpax Pharmaceuticals Inc (VRPX) estimates and forecasts
Revenue is forecast to grow 90.60% this quarter before jumping 88.60% for the next one.
VRPX Dividends
Virpax Pharmaceuticals Inc has its next earnings report out on 2024-Aug-12. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX)’s Major holders
Virpax Pharmaceuticals Inc insiders hold 6.16% of total outstanding shares, with institutional holders owning 0.50% of the shares at 0.53% float percentage. In total, 0.50% institutions holds shares in the company, led by PARALLEL ADVISORS, LLC. As of 2024-06-30, the company held over 1.0 shares (or 0.0001% of shares), all amounting to roughly $1.0.
We also have Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Virpax Pharmaceuticals Inc (VRPX) shares. Going by data provided on Mar 31, 2024 , Vanguard Extended Market Index Fund holds roughly 6.63 shares. This is just over 0.14% of the total shares, with a market valuation of $5651.0. Data from the same date shows that the other fund manager holds a little less at 4.33, or 0.09% of the shares, all valued at about 3694.0.
